European Commission Introduces Critical Medicines Act to Address Drug Shortages in March 2025

The European Commission has introduced the Critical Medicines Act, a legislative proposal aimed at addressing drug shortages across member states. Announced in March 2025, the act seeks to enhance the availability and supply of essential medicines within the European Union. The initiative is designed to tackle recurring challenges in pharmaceutical supply chains and ensure that critical medications remain accessible to patients who need them.

The proposal outlines measures intended to strengthen production capacities, improve coordination among EU countries, and establish mechanisms for monitoring medicine supplies more effectively. By focusing on critical drugs, the act aims to mitigate disruptions caused by factors such as manufacturing delays or global crises. The legislation also emphasizes collaboration with industry stakeholders and regulatory bodies to streamline processes and reduce bottlenecks in distribution networks. Further details regarding implementation timelines and specific provisions are expected as discussions progress within the EU framework.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: April 10, 2025

Author

Mark Chiang